SLC22A1 and epilepsy: SLC22A1 was shown to contribute to altered lamotrigine (LTG) plasma concentrations during AED treatment [52], but no SLC22A1 variants have been shown to cause or affect epilepsy to date; thus, we regard it as an undetermined gene.